Abstract: Yohimbine (1), an indole alkaloid, was isolated from the dried bark of the tropical West African tree Pausinystalia yohimbe. It was approved by the US FDA for erectile dysfunction. Microbial systems serve as in vitro convenient, reliable, and predictive models for drug metabolism study in mammals, including man. Microbial bioconversion studies conducted on yohimbine have revealed that it was metabolized by Bacillus cereus var. fluorescens ATCC 13824 to give 18β-hydroxyyohimbine (2) and 21α-hydroxyyohimbine (3). Their structures were established on the basis of their spectral data, and in comparison with those of the substrate yohimbine.
These side effects may be parent drug-related or metabolites-related. In order to rule out the first possibility, metabolites in quantities enough to test their pharmacological effects are needed.
One important method used to furnish enough metabolites is the use of microorganisms, because they can serve as convenient, reliable, and predictive models for mammalian drug metabolism [11] . Microbial systems have the advantages of being efficient catalysts, act under mild conditions, catalyze a wide range of reactions, not restricted to their natural substrates, and chemo-, regio-and stereoselective [12] . This method produces significant quantities of metabolites that would be difficult to obtain from either animal system or chemical synthesis. The result from this method often parallel these obtained from human biotransformation and, thus, can be predictive.
Yohimbine aromatic ring hydroxylation was reported to happen in man and microorganisms, as well. 9-hydroxy, 10-hydroxy, 11-hydroxy and 12-hydroxyyohimbine were reported previously as human [13] and microbial metabolites [14] [15] [16] .
It is anticipated that the microbial metabolism of yohimbine would also produce some new analogues that may serve as prospective candidates for antierectile dysfunction evaluation or as a starting leads for the semisynthesis of other derivatives. This note reports on the microbial transformation of yohimbine and the subsequent isolation and characterization of its metabolites.
MATERIALS AND METHODS
The IR spectra were recorded using Jasco FTIR-4100 spectrophotometer (Easton, MD, USA). UV spectra were measured in methanol using Shimadzu UV-1601 UV-visible spectrophotometer (Kyoto, Japan C NMR spectra of 2 and 3 were recorded in DMSO-d 6 and in CDCl 3 , respectively, and the chemical shift values were expressed in δ (ppm) relative to the internal standard TMS. For the 13 C NMR spectra, the number of attached protons was determined by DEPT 135°. 2D NMR spectroscopic data were obtained using the standard pulse sequence of the Bruker Avance II for COSY, HSQC, HMBC and NOESY. The HRMS spectra were measured on Thermo Finnigan mass spectrophotometer (Bermen, Germany) with electrospray ionization. CC used silica gel 60 (230-400 mesh ASTM, Merck, Darmstadt, Germany) for purifications. Precoated TLC plates (silica gel) were used to check the purity of compounds, and Dragendorff's spraying reagent was used for staining of the compounds on TLC. A commercial sample of Yohimbine HCl was purchased from Sigma and used in this work. All reagents used were of analytical grades.
Cultures and Fermentation Screening Procedure
The microbial cultures were originally obtained from the American Type Culture Collection (ATCC), Rockville, Maryland, and are maintained at Kuwait University, Department of Pharmaceutical Chemistry Culture Collection. Stock cultures were maintained on agar slants of media recommended by the ATCC and were stored at 4 °C.
All the preliminary screening and preparative-scale experiments were carried as reported before [11] and according to the standard two-stage protocol [17] . Twenty microbial cultures ( Table 1) were screened using twenty (250 mL) Delong culture flasks. The culture flasks held one fifth of their volume the universal medium α containing per liter, 20 g glucose, 5 g yeast extract, 5 g peptone extract, 5 g NaCl, and 5 g K 2 HPO 4 in distilled water. This composition provided a pH of 7.2. The medium was autoclaved for 20 min at 121°C. The culture flasks were inoculated with twenty different microorganisms and incubated on a Lab-Line orbital shaker (SHKE3000-ICE, Mumbai, India) operating at 170 rpm and 25±1 ºC (stage I). After 72 h, 5 mL of stage I cultures were used to inoculate another twenty (250 mL) sterile medium flasks and left for 24h (stage II). Yohimbine was prepared as a 10 % solution in N,N-dimethylformamide (DMF) and added to the 24-h-old stage II culture flasks at a concentration of 0.1 mg/mL of medium. Substrate control was composed of sterile medium to which the substrate (5 mg/50 µL DMF) was added and incubated without microorganisms. Culture controls consisted of fermentation blanks in which the microorganisms were grown under identical conditions but without the substrate addition. After 14 days of incubation, test and controls were harvested by extraction with CHCl 3 and analyzed by TLC. 
Absidia glauca ATCC 22752
Acinetobacter calcoaceticus ATCC 14987
Agrobacterium tumefaciens ATCC15955
Alcaligenes eutrophus ATCC 17697
Aspergillus fumigatus ATCC 1022
Aspergillus niger ATCC 16888

Bacillus cereus var. fluorescens ATCC 13824
Beauveria bassiana ATCC 7159
Cellulomonas flavigena ATCC 482
Cunninghamella blakesleeana ATCC 9245
Cunninghamella echinulata var. echinulata ATCC 9244
Cunninghamella homothallica ATCC 16161
Cylindrocarpon radicicola ATCC 11011
Flavobacterium oxydans ATCC 21245
Mucor circinelloides f. griseocyanus 1207a
Mucor griseocyanus ATCC 1207b
Nocardia coralline ATCC 19148
Rhizopus arrhizus ATCC 11145
Rhizopus stolonifer ATCC 24795
Sphingobacterium heparinum ATCC 13125 a Microorganisms in bold represent those gave positive results.
Preparative Scale Fermentation by Bacillus cereus var. fluorescens ATCC 13824
Under similar culture conditions (temperature and shaking speed) to the screening stage, Bacillus cereus var. fluorescens ATCC 13824 was grown in five 1-L culture flasks each containing 200 mL of medium α. After 72 h, 20 mL of stage I culture were used to inoculate another fifty 1-L sterile medium flasks and left for 24h (stage II), then a total of 1 gm of yohimbine (in 2.5 mL DMF) was evenly distributed among these flasks. After 14 days, the incubation mixtures were checked by TLC. TLC revealed that most of yohimbine was transformed and two more polar metabolites were produced.
Isolation and Purification of the Metabolites
After two weeks of incubation, cultures were combined and exhaustively extracted with 3x4 liters of CHCl 3 after alkalinizing the media with concentrated NH 4 OH solution (pH=9). The combined CHCl 3 layers were concentrated down to 250 mL and, then, subjected to an acid/base shake up using equal volumes of acidified (6M HCl) and alkalinized (concentrated NH 4 OH) water. The water layers were re-extracted with CHCl 3 . Finally, the CHCl 3 extract was dried over anhydrous Na 2 SO 4 and concentrated under reduced pressure to afford brown syrupy residue. This residue (2.29 g) was chromatographed over silica gel column (250 g, 5 x 60 cm) using a mixture of CHCl 3 : CH 3 OH: concentrated NH 4 OH (8:1:0.8 v/v) as a mobile phase. Fractions of 25 mL each were collected and analyzed by TLC. Similar fractions were pooled together. This afforded three main fractions; A, B and C. Fraction A gave 595.8 mg of the recovered substrate. Fraction B and C afforded impure metabolites 2 and 3 in 39.5 mg and 21.7 mg, respectively.
Fraction B was subjected to another column chromatographic separation using CH 3 CN: CH 3 OH: C 2 H 5 NH 2 in the ratio of (8.3:1.7:0.5 v/v) as a mobile phase to afford the semi-pure metabolite 2 which yielded 21.5 mg of pure metabolite 2 after crystallization from a mixture of 1% of CHCl 3 in CH 3 CN.
Fraction C was purified using preparative TLC eluted with a mixture of CHCl 3 : CH 3 OH: concentrated NH 4 OH (8.5:1.5:0.08 v/v) to afford 14.4 mg of pure metabolite 3.
Metabolite 2
Colorless powder; IR neat υ max 3300 (OH), 2919 (C-H), 1735 (C=O) cm Table 1 ). All of them produced one common nitrogen containing metabolite (2) . Bacillus cereus var. fluorescens ATCC 13824 produced 2 in a much higher yield, in addition to another nitrogen-containing metabolite (3). Therefore, Bacillus cereus var. fluorescens ATCC 13824 was selected for preparative scale fermentation to produce these metabolites in quantities enough for structural elucidation and other potential biological studies.
Preparative scale biotransformation of 1 g of yohimbine using Bacillus cereus var. fluorescens ATCC 13824 afforded 21.5 mg of metabolite 2 (2.06 % yield, colorless powder) and 14.4 mg of metabolite 3 (1.38 % yield, colorless powder).
ESIMS of 2 indicated that its molecular weight is m/z 370.1862, which is consistent with the molecular formula C 21 H 26 N 2 O 4 . The IR spectrum showed a broad absorption band at 3300 cm -1 which suggested the presence of at least one hydroxyl group. The strong absorption band at 2919 cm -1 was attributed to saturated C-H stretch, while the presence of a strong absorption band at 1735 cm -1 indicated the presence of an ester carbonyl group.
13
C NMR spectrum ( Table 2 ) of 2 showed 21 carbon resonances distributed as five singlets, ten doublets, five triplets and one quartet. Carbon multiplicities showed that 2 has one less triplet (δ C 30.9) and, on the other hand, one more oxygenated doublet (C-18, δ C 68.8), when compared to yohimbine, suggesting the bioconversion of yohimbine into hydroxyyohimbine.
Six carbon resonances were in the aliphatic deshielded region (δ C 50-80). Three of these carbons were the ones attached to N-4 (C-3, δ C 60.0, C-5, δ C 52.5, and C-21, δ C 63.8). HSQC spectra showed a correlation between the carbon resonated at δ C 68.8 and a proton signal resonated as ddd (J= 5.3, 5.3, 5.3) at δ H 4.85 ( Table 2) . This proton was shown to possess a cross peak in the COSY spectrum with another proton resonating as a broad singlet at δ H 4.13, assigned to H-17. H-17 showed 1 J-correlation, in HSQC spectrum, with a doublet carbon resonating at δ C 66.3. This confirmed the conclusion that the new oxygenated carbon is C-18. It is worthnoting the downfield shift of C-19 (∆ 4.5 ppm). On the other hand, C-20 showed an upfield shift (∆ 2.9 ppm) when compared to the same carbons of yohimbine. HMBC spectrum showed Non-spinning mode NOESY spectrum showed a cross peak between H-18 and H 3 -23 resonating as a sharp singlet at δ H 3.68. This proves that those protons should be on the same side of the molecule, i.e., α-disposition. Consequently, the hydroxyl group on C-18 should adopt the β-orientation. Other NMR data were similar to those of yohimbine as shown in Table 2 . Hence, the identity of metabolite 2 was proposed to be the new metabolite 18β-hydroxyyohimbine. C-18 epimer, 18α-hydroxyyohimbine, has been reported before as a microbial metabolite [14, 18] .
Metabolite 3 was shown to possess the molecular formula C 21 H 26 N 2 O 4 , as was derived from the molecular ion peak at m/z 370.1881 and from NMR spectral data ( Table 2 ). The presence of at least one hydroxyl group was clearly shown in the IR spectrum from the broad absorption band at 3309 cm -1 . The strong absorption band at 2920 cm -1 was attributed to the presence of saturated C-H stretch. The introduction of another hydroxyl group was established from 13 C NMR data. 13 C NMR and DEPT spectra revealed the presence of one methyl, five methylene, ten methine, and five quaternary carbons. These resonances were similar to those of 2 and suggested that metabolite 3 is another hydroxyyohimbine derivative.
Five carbons, resonated between δ C 50-80, were concluded to be aliphatic ones attached to electronwithdrawing atoms. C-3 resonated at δ C 61.8 as a doublet, C-5 as a triplet at δ C 56.8, C-17 as a doublet at δ 66.3, C-23 as a quartet at δ 52.3, while C-21 resonated more downfield, when compared to yohimbine C-21, as a doublet at δ C 72.3. This carbon was suggested to have the newly introduced hydroxyl group, in addition to the original N atom. HSQC spectrum showed a correlation between this carbon and a proton resonated at δ H 4.15 (d, J= 6.0 Hz, H-21).
HMBC spectra showed a 3 J-correlation between the methyl protons (δ H 3.65, s) and the carbonyl carbon (δ C 174.2). Other important correlations existed in the aromatic region, between H-9 (δ H 7.35, d) and C-11 (δ C 122.0) and C-13 (δ C 136.7), H-10 (δ H 6.99, dd) and C-8 (δ C 126.0) and C-12 (δ C 112.0), H-11 (δ H 7.07, dd) and C-9 (δ C 117.9) and C-13 (δ C 136.7). Other NMR data were similar to those of 2.
1
H NMR coupling constant and pattern of H-21 (d, J= 6.0 Hz) indicated that this proton should be an equatorial one. Since the ringjunction proton, H-20, is adopting the axial β-disposition, therefore, H-21 should be adopting the equatorial β-disposition, as well, leaving the α-orientation for the coming hydroxyl group. Consequently, metabolite 3 was concluded to be the new 21α-hydroxyyohimbine.
Metabolites 2 and 3 might represent new leads as anti-erectile drugs.
